CDKN1A and hepatocellular carcinoma: HPGD has been shown to regulate the 15-keto-PGE2/peroxisome proliferator-activated receptor-γ/p21 (WAF1/Cip1) signaling pathway to suppress hepatocellular carcinoma growth46.